Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline

doi:10.1111/bjh.15235

Practice Guideline

. 2018 May;181(4):460-475.

doi: 10.1111/bjh.15235. Epub 2018 May 6.

Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline

Amrana Qureshi¹, Banu Kaya², Shivan Pancham³, Russell Keenan⁴, Jeremy Anderson⁵, Magbor Akanni⁶, Jo Howard⁷; British Society for Haematology

Affiliations

¹ Department of Paediatric Haematology and Oncology, Oxford Children's Hospital, Oxford University Hospital NHS Trust, Oxford, UK.
² Department of Paediatric Haematology and Oncology, Royal London Hospitals, Barts Health NHS Trust, London, UK.
³ Department of Haematology, Sandwell and West Birmingham NHS Trust, West Bromwich, UK.
⁴ Department of Paediatric Haematology, Alderhey Children's Hospital NHS Trust, Liverpool, UK.
⁵ Department of Clinical Psychology, Imperial College Healthcare NHS Trust, London, UK.
⁶ Department of Haematology, Milton Keynes Hospital NHS Trust, Milton Keynes, UK.
⁷ Department of Haematology, Guys and St Thomas's NHS Foundation Trust, London, UK.

PMID: 29732531
DOI: 10.1111/bjh.15235

Free article

Practice Guideline

Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline

Amrana Qureshi et al. Br J Haematol. 2018 May.

Free article

. 2018 May;181(4):460-475.

doi: 10.1111/bjh.15235. Epub 2018 May 6.

Authors

Amrana Qureshi¹, Banu Kaya², Shivan Pancham³, Russell Keenan⁴, Jeremy Anderson⁵, Magbor Akanni⁶, Jo Howard⁷; British Society for Haematology

Affiliations

¹ Department of Paediatric Haematology and Oncology, Oxford Children's Hospital, Oxford University Hospital NHS Trust, Oxford, UK.
² Department of Paediatric Haematology and Oncology, Royal London Hospitals, Barts Health NHS Trust, London, UK.
³ Department of Haematology, Sandwell and West Birmingham NHS Trust, West Bromwich, UK.
⁴ Department of Paediatric Haematology, Alderhey Children's Hospital NHS Trust, Liverpool, UK.
⁵ Department of Clinical Psychology, Imperial College Healthcare NHS Trust, London, UK.
⁶ Department of Haematology, Milton Keynes Hospital NHS Trust, Milton Keynes, UK.
⁷ Department of Haematology, Guys and St Thomas's NHS Foundation Trust, London, UK.

PMID: 29732531
DOI: 10.1111/bjh.15235

No abstract available

PubMed Disclaimer

Cited by

Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot study.
Casella JF, Furstenau DK, Adams RJ, Brambilla DJ, Lebensburger JD, Fehr JJ, Jordan LC, King AA, Ichord RN, McKinstry RC, Kraut MA, Shaw DW, White DA, Whyte-Stewart DA, Avadhani R, Barron-Casella EA, Cannon AD, Eaton CK, Riekert KA, Shay JE, Smith-Seidel CA, Weiss DC, Ostapkovich ND, Vermillion K, Treine KE, Kingsbury CE, Strouse JJ, Thompson RE, Hanley DF. Casella JF, et al. Am J Hematol. 2024 Oct;99(10):1906-1916. doi: 10.1002/ajh.27423. Epub 2024 Jul 2. Am J Hematol. 2024. PMID: 38953438 Clinical Trial.
Haemoglobin Ottawa, sickle cell trait and vaso-occlusive crises.
Bobillier C, Derclaye I, Ferrant A, Maisin D. Bobillier C, et al. EJHaem. 2024 Feb 12;5(1):33-38. doi: 10.1002/jha2.857. eCollection 2024 Feb. EJHaem. 2024. PMID: 38406508 Free PMC article.
Impact of Hydroxyurea to Treat Haematological Disorders on Male Fertility: Two Case Reports and a Systematic Review.
Cilio S, Fallara G, Lupo Stanghellini MT, Ciceri F, Montorsi F, Lunghi F, Salonia A. Cilio S, et al. World J Mens Health. 2024 Jul;42(3):531-542. doi: 10.5534/wjmh.230069. Epub 2024 Jan 2. World J Mens Health. 2024. PMID: 38164027 Free PMC article.
Madrid Newborn Sickle Cell Disease Cohort: clinical outcomes, stroke prevention and survival.
García-Morin M, Bardón-Cancho EJ, Beléndez C, Dulín E, Blanco-Soto P, Puertas-López C, Prieto-Medina M, Cervera-Bravo Á, Llorente-Otones L, Pérez-Alonso V, San-Román S, Vecilla-Rivelles C, López-Rubio M, Sebastián E, Bellón JM, Cela E. García-Morin M, et al. Ann Hematol. 2024 Feb;103(2):373-383. doi: 10.1007/s00277-023-05539-1. Epub 2023 Nov 18. Ann Hematol. 2024. PMID: 37980280
Prospective identification of variables as outcomes for treatment (PIVOT): study protocol for a randomised, placebo-controlled trial of hydroxyurea for Ghanaian children and adults with haemoglobin SC disease.
Smart LR, Segbefia CI, Latham TS, Stuber SE, Amissah-Arthur KN, Dzefi-Tettey K, Lane AC, Dei-Adomakoh YA, Ware RE. Smart LR, et al. Trials. 2023 Sep 22;24(1):603. doi: 10.1186/s13063-023-07649-7. Trials. 2023. PMID: 37737189 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline

Affiliations

Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline

Authors

Affiliations

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical